CaptureSelect Affinity Antibody Resins Cinematic
1:01
CaptureSelect® products possess a combination of unique properties, including selectivity, affinity, and stability.
Related Videos
In Bioprocessing Videos
-
Play video Navigating global regulatory landscapes in an evolving biopharma industry
Navigating global regulatory landscapes in an evolving biopharma industry
Join our webinar for expert insights, engaging discussions, and interactive Q&A sessions. Discover the latest trends, expand your knowledge, and connect with professionals in your field. Don’t miss this chance to enhance your skills and stay ahead!
27:52
-
Play video E-Gel Power Snap Plus Cinematic
E-Gel Power Snap Plus Cinematic
The Invitrogen E-Gel Power Snap Plus Electrophoresis System is a compact, precast agarose gel running and imaging station.
0:39
-
Play video The Upstream Advantage: Unlocking bioprocessing potential
The Upstream Advantage: Unlocking bioprocessing potential
Hear from Thermo Fisher Scientific colleagues and learn about their perspectives on the future of bioprocessing.
3:26
-
Play video Gibco Efficient Pro Feed 3 Protein Production Workflow
Gibco Efficient Pro Feed 3 Protein Production Workflow
Boost CHO-K1 GS titers by up to 146% with Efficient-Pro Feed 3 and Feed Enhancer—a two-part, chemically defined, animal-origin-free system designed with advanced metabolomics to enhance productivity and maintain critical product quality.
1:41
-
Play video How to operate a Thermo Scientific DynaDrive 5L Single-Use Bioreactor
How to operate a Thermo Scientific DynaDrive 5L Single-Use Bioreactor
Watch a walkthrough of how to properly operate a Thermo Scientific DynaDrive 5L Single-Use Bioreactor.
8:28
-
Play video Gibco CHOvantage GS Cell Line Development Kit
Gibco CHOvantage GS Cell Line Development Kit
Advance from transfection to high-producing CHO clones faster with the Gibco CHOvantage cell line development workflow. Achieve strong productivity, stable expression, consistent quality and scalable performance to support biotherapeutic development.
1:27
